This strong commercial momentum is fueled by the global expansion of its clinical-grade Breast AI Suite, now completed with the
The clinical validation and regulatory certification of Ibex’s breast IHC workflow is expected to further boost pathology lab performance and
Top experts Dr. Ruth March and Dr. Paolo Tarantino named as members, with additional appointments to follow TEL AVIV, Israel
Digital pathology leader surpasses 250,000 AI-based analyses in routine clinical use as it incorporates Ibex Prostate for TURP to further
HNL Lab Medicine to integrate Ibex’s AI-powered solution for prostate cancer, building on its existing digital pathology foundation to support
The platform features an enhanced user experience and end-to-end breast workflow with automated H&E analysis and “zero-click” IHC quantification, supporting
Integration Delivers Seamless Workflow Combining AI-Powered Cancer Diagnosis with CAP, RCPath, and ICCR-Compliant Structured Reporting BOSTON, MA and CENTERVILLE, MA
Yair Heller Appointed CEO and Co-Founder Joseph Mossel to Lead Strategic Growth Initiatives as Ibex Accelerates Global Impact BOSTON &
January 6, 2026 Ibex Medical Analytics, the global leader in clinical-grade AI-powered pathology, today announced a significant expansion of its
September 4, 2025 Ibex Medical Analytics (Ibex), a leader in artificial intelligence (AI)-powered cancer diagnostics, today announced it has received